Press-release for stocks related to bioscience for cstl

Prices are updated after-hours

Castle Biosciences Reports First Quarter 2022 Results
Published: 2022-05-09 (Crawled : 21:00) - biospace.com/
CSTL | $20.06 2.3% 2.05% 25

| -5.15% | O: -3.31% H: 0.0% C: 0.0%
results bioscience

Castle Biosciences Completes Acquisition of AltheaDx
Published: 2022-04-26 (Crawled : 22:00) - biospace.com/
CSTL | $20.06 2.3% 2.05% 25

| -15.79% | O: -1.53% H: 0.0% C: 0.0%
acquisition bioscience

Castle Biosciences to Acquire AltheaDx
Published: 2022-04-04 (Crawled : 22:00) - biospace.com/
CSTL | $20.06 2.3% 2.05% 25

| -56.37% | O: 0.8% H: 1.98% C: -0.78%
bioscience

| -53.84% | O: -0.4% H: 4.29% C: 0.94%
day financial results ces conference bioscience results

Castle Biosciences to Present at the 11th Annual SVB Leerink Global Healthcare Conference
Published: 2022-02-07 (Crawled : 13:00) - biospace.com/
CSTL | $20.06 2.3% 2.05% 25

| -52.72% | O: 1.0% H: 6.93% C: 2.94%
health ces thc conference bioscience svb leerink global

| -52.98% | O: -5.98% H: 5.36% C: 3.96%
decisiondx test bioscience cancer

PreludeDx™ Announces the Appointment of Derek J. Maetzold of Castle Biosciences to its Board of Directors
Published: 2022-02-02 (Crawled : 12:30) - biospace.com/
CSTL | $20.06 2.3% 2.05% 25

| -54.4% | O: -3.02% H: 0.0% C: 0.0%
ces bioscience

Castle Biosciences Named a Winner of the 2022 Top Workplaces USA Award
Published: 2022-02-02 (Crawled : 12:30) - biospace.com/
CSTL | $20.06 2.3% 2.05% 25

| -54.4% | O: -3.02% H: 0.0% C: 0.0%
ces work bioscience

Castle Biosciences Announces Preliminary Fourth Quarter and Full-Year 2021 Results
Published: 2022-01-10 (Crawled : 13:30) - biospace.com/
CSTL | $20.06 2.3% 2.05% 25

| -50.0% | O: -1.72% H: 2.18% C: 2.03%
bioscience

Castle Biosciences to Present at the 24th Annual Needham Growth Conference
Published: 2021-12-28 (Crawled : 13:00) - biospace.com/
CSTL | $20.06 2.3% 2.05% 25

| -51.77% | O: 0.53% H: 1.63% C: -1.46%
conference annual needham bioscience growth

Castle Biosciences Completes Acquisition of Cernostics
Published: 2021-12-06 (Crawled : 13:00) - biospace.com/
CSTL | $20.06 2.3% 2.05% 25

| -52.0% | O: -1.42% H: 0.0% C: 0.0%
acquisition bioscience

Castle Biosciences Presents Data Reinforcing the Clinical Utility of Its DecisionDx® Dermatologic Portfolio
Published: 2021-11-24 (Crawled : 12:30) - biospace.com/
CSTL | $20.06 2.3% 2.05% 25

| -54.82% | O: -1.78% H: 0.0% C: 0.0%
decisiondx bioscience

Castle Biosciences Named in Inc.’s First-Annual Best-Led Companies
Published: 2021-11-17 (Crawled : 13:00) - biospace.com/
CSTL | $20.06 2.3% 2.05% 25

| -61.45% | O: 3.96% H: 0.0% C: -3.12%
bioscience